Compounds > gyki 52466
Page last updated: 2024-10-28

gyki 52466 and Acute Confusional Senile Dementia

gyki 52466 has been researched along with Acute Confusional Senile Dementia in 1 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scriabine, A1

Other Studies

1 other study available for gyki 52466 and Acute Confusional Senile Dementia

ArticleYear
The Neurobiology and Neuropharmacology of Alzheimer's Disease. The ASPET - Ray Fuller Symposium. New Orleans, LA, USA, April 19-20, 2002.
    CNS drug reviews, 2002,Fall, Volume: 8, Issue:3

    Topics: Alzheimer Disease; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzothiadiazines; Humans; Neurobi

2002